Overview

Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and tolerability of QAT370 compared to tiotropium in patients with COPD.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis
Treatments:
Tiotropium Bromide